455 related articles for article (PubMed ID: 17395594)
1. Cellular characterization of a novel focal adhesion kinase inhibitor.
Slack-Davis JK; Martin KH; Tilghman RW; Iwanicki M; Ung EJ; Autry C; Luzzio MJ; Cooper B; Kath JC; Roberts WG; Parsons JT
J Biol Chem; 2007 May; 282(20):14845-52. PubMed ID: 17395594
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase inhibitors are potent anti-angiogenic agents.
Cabrita MA; Jones LM; Quizi JL; Sabourin LA; McKay BC; Addison CL
Mol Oncol; 2011 Dec; 5(6):517-26. PubMed ID: 22075057
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
Aboubakar Nana F; Lecocq M; Ladjemi MZ; Detry B; Dupasquier S; Feron O; Massion PP; Sibille Y; Pilette C; Ocak S
Mol Cancer Ther; 2019 Jan; 18(1):17-27. PubMed ID: 30352800
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.
Stokes JB; Adair SJ; Slack-Davis JK; Walters DM; Tilghman RW; Hershey ED; Lowrey B; Thomas KS; Bouton AH; Hwang RF; Stelow EB; Parsons JT; Bauer TW
Mol Cancer Ther; 2011 Nov; 10(11):2135-45. PubMed ID: 21903606
[TBL] [Abstract][Full Text] [Related]
5. Effect of focal adhesion kinase inhibition on osteoblastic cells grown on titanium with different topographies.
Lopes HB; Souza ATP; Freitas GP; Elias CN; Rosa AL; Beloti MM
J Appl Oral Sci; 2020; 28():e20190156. PubMed ID: 32049134
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells.
Hiscox S; Barnfather P; Hayes E; Bramble P; Christensen J; Nicholson RI; Barrett-Lee P
Breast Cancer Res Treat; 2011 Feb; 125(3):659-69. PubMed ID: 20354780
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel focal adhesion kinase inhibitor in human platelets.
Jones ML; Shawe-Taylor AJ; Williams CM; Poole AW
Biochem Biophys Res Commun; 2009 Nov; 389(1):198-203. PubMed ID: 19716803
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.
Roberts WG; Ung E; Whalen P; Cooper B; Hulford C; Autry C; Richter D; Emerson E; Lin J; Kath J; Coleman K; Yao L; Martinez-Alsina L; Lorenzen M; Berliner M; Luzzio M; Patel N; Schmitt E; LaGreca S; Jani J; Wessel M; Marr E; Griffor M; Vajdos F
Cancer Res; 2008 Mar; 68(6):1935-44. PubMed ID: 18339875
[TBL] [Abstract][Full Text] [Related]
9. LEFTY2 Controls Migration of Human Endometrial Cancer Cells via Focal Adhesion Kinase Activity (FAK) and miRNA-200a.
Alowayed N; Salker MS; Zeng N; Singh Y; Lang F
Cell Physiol Biochem; 2016; 39(3):815-26. PubMed ID: 27497669
[TBL] [Abstract][Full Text] [Related]
10. Anthocyanidins, novel FAK inhibitors, attenuate PDGF-BB-induced aortic smooth muscle cell migration and neointima formation.
Son JE; Lee E; Jung SK; Kim JE; Oak MH; Lee KW; Lee HJ
Cardiovasc Res; 2014 Mar; 101(3):503-12. PubMed ID: 24363205
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells.
Tse KW; Lin KB; Dang-Lawson M; Guzman-Perez A; Aspnes GE; Buckbinder L; Gold MR
Cell Immunol; 2012; 275(1-2):47-54. PubMed ID: 22507871
[TBL] [Abstract][Full Text] [Related]
12. FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth.
Tancioni I; Miller NL; Uryu S; Lawson C; Jean C; Chen XL; Kleinschmidt EG; Schlaepfer DD
Breast Cancer Res; 2015 Mar; 17():47. PubMed ID: 25880415
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate.
Kunit T; Gratzke C; Schreiber A; Strittmatter F; Waidelich R; Rutz B; Loidl W; Andersson KE; Stief CG; Hennenberg M
Am J Physiol Renal Physiol; 2014 Oct; 307(7):F823-32. PubMed ID: 25056351
[TBL] [Abstract][Full Text] [Related]
14. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
[TBL] [Abstract][Full Text] [Related]
15. PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments.
Tanjoni I; Walsh C; Uryu S; Tomar A; Nam JO; Mielgo A; Lim ST; Liang C; Koenig M; Sun C; Patel N; Kwok C; McMahon G; Stupack DG; Schlaepfer DD
Cancer Biol Ther; 2010 May; 9(10):764-77. PubMed ID: 20234191
[TBL] [Abstract][Full Text] [Related]
16. The focal adhesion kinase inhibitor PF-562,271 impairs primary CD4+ T cell activation.
Wiemer AJ; Wernimont SA; Cung TD; Bennin DA; Beggs HE; Huttenlocher A
Biochem Pharmacol; 2013 Sep; 86(6):770-81. PubMed ID: 23928188
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
Chauhan A; Khan T
Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo.
Liu TJ; LaFortune T; Honda T; Ohmori O; Hatakeyama S; Meyer T; Jackson D; de Groot J; Yung WK
Mol Cancer Ther; 2007 Apr; 6(4):1357-67. PubMed ID: 17431114
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting focal adhesion kinase (FAK) blocks IL-4 induced VCAM-1 expression and eosinophil recruitment in vitro and in vivo.
Aulakh GK; Petri B; Wojcik KM; Colarusso P; Lee JJ; Patel KD
J Leukoc Biol; 2018 Jul; 104(1):147-158. PubMed ID: 29633338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
